Transforming detection
“The COVID-19 pandemic makes it clear how urgent the need is for a new generation of fast, low-cost surveillance and diagnostics tools,” explains Paul Mola, CEO of Roswell Biotechnologies. “Our molecular electronics platform will transform the way infectious diseases are detected, offering powerful new capabilities that enable the rapid and simultaneous screening of numerous infectious diseases such as COVID-19 and viral strains, using only portable devices.”